Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01932294 · ClinicalTrials.gov registry record
Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
A clinical trial of Heart Failure and Systolic Heart Failure, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 171
- Enrollment target
- 11
- Study locations
NCT01932294 is a study of Heart Failure and Systolic Heart Failure that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 171 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 11 study locations across 10 states.
The verdict
NCT01932294, a study of Heart Failure and Systolic Heart Failure, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
- 11
- Study locations
Study Summary
Medamacs is a prospective, observational study of ambulatory patients with advanced heart failure. The study enrolls patients who have not yet received a Left Ventricular Assist Device (LVAD) but who receive their care at a hospital with a Joint Commission certified mechanical circulatory support program. Medamacs is funded through the Interagency for Mechanically Assisted Circulatory Support (INTERMACS) NHLBI Contract.
Conditions Studied
Study Locations (11)
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Cedars Sinai Medical Center - Beverly Hills
Colorado
- University of Colorado - Aurora
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Massachusetts
- Brigham and Women's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-01-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01932294
The ClinicalTrials.gov registry entry for NCT01932294 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT01932294 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Pennsylvania, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT01932294 about?
NCT01932294 is a clinical study titled "Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support". Medamacs is a prospective, observational study of ambulatory patients with advanced heart failure. The study enrolls patients who have not yet received a Left Ventricular Assist Device (LVAD) but who receive their care at a hospital with a Joint Commission certified mechanical circulatory support pr...
What is the current status of trial NCT01932294?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2013-04. Estimated completion is 2017-01-20.
What conditions does trial NCT01932294 study?
This clinical trial studies the following conditions: Heart Failure, Systolic Heart Failure.
Who is sponsoring clinical trial NCT01932294?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01932294 being conducted?
This trial has 11 study locations across Alabama, California, Colorado, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.